Today the NHMRC announced University of Sydney scholars will receive more than $69 million in the final round of funding for 2017, bringing the total amount of NHMRC funding for the year to over $97 million.
Sydney scholars have been awarded more than $69 million in the latest round of funding from the National Health and Medical Research Council (NHMRC) to develop new drugs that can reduce cancer spreading and create new ways to predict whether a kidney transplant will fail, among many other critically important projects.
Announced on Wednesday (6 December), Sydney researchers received more than $40 million for 49 Project Grants and $25 million for two Program Grants. A further $813,000 was awarded for one Global Alliance for Chronic Diseases Grant and 12 Sydney students also received postgraduate scholarships, valued at almost $900,000.
Deputy Vice-Chancellor (Research) Professor Duncan Ivison said the results were outstanding, bringing the total amount of NHMRC funding received this year to $97.1 million, the second highest awarded to a single institution nationally.
“It’s an incredible result that our health and medical researchers should be proud of and reflects the University’s strength in medical sciences,” he said, adding that this year, the University was again ranked 1st in Australia for medicine in the QS World University Rankings by Subject.
“We’re proud to support some of the best medical researchers in the world – as well as the next generation of talented postgraduate scholars – to develop new preventions and treatments for devastating diseases such as cancer, multiple sclerosis and diabetes. This important work will vastly improve the health and quality of life for millions around the world.”
Highlights of grants awarded to Sydney researchers in this round include: